In The News

In Law360, Health Care Attorneys Analyze State Efforts to Regulate Drug Prices and Federal Barriers

Practices: Health Care, Health Care Finance & Restructuring, Life Sciences, Administrative Litigation

In a Law360 article published on Feb. 12, health care partner Deborah Kantar Gardner (Boston) and associate Scott Falin (Washington, D.C.) examine various state efforts to control drug prices and the constitutional and federal limits on those reforms.

The authors explain that state drug pricing laws take a variety of forms, ranging from importation to rate setting to price transparency. While states have pressed forward with creative and targeted initiatives aimed at reducing drug costs, constitutional and federal authority often impedes their ability to implement fully the reforms they seek.

Cookie Settings